ADVERTISEMENT
Infectious Diseases Data Verified

COVID-19 Vaccines and Kids

Published on May 28, 2021 and last reviewed on Aug 09, 2021   -  4 min read

Abstract

Children are more prone to fall ill, and they have traditionally been the primary recipient of vaccines. Please read the article to know should we start vaccinating our children against COVID-19.

Contents
COVID-19 Vaccines and Kids

Introduction:

On considering the COVID-19 outbreak, parents are alarmed to register their children under a COVID-19 vaccine. The clinical trials for vaccinating children against this infectious disease are still under process. Scientists are seeking answers to prove how safe and effective vaccines are in children. It is still confusing that:

Researchers asked the Food and Drug Administration (FDA) to extend its vaccine ​authorization for children as young as 12 years, and the clinical trials start in children as young as six months old. We should not assume that the vaccine will provide the same response in children as it does for adults. So, clinical trials should be completed to ensure the safety and effectiveness of children and younger teens before COVID-19 vaccines become available for them.

Do We Need to Vaccinate Children?

COVID-19 in kids is rare, and only one case in 1000 or even lower is diagnosed. Kids developing severe forms of COVID-19 and experiencing death is an extremely rare condition. It is noted that kids who had mild infections of COVID-19 developed multisystem inflammatory syndrome (MIS-C). The proven evidence of the COVID-19 vaccine blocking the transmission of the SARS-CoV-2 virus has given us the thought of vaccinating children for wider protection, but children are not super-spreaders. It is important to have herd immunity across all groups, and so children who can be susceptible to transmitting the virus need to be vaccinated. This is because the virus will continue to spread and survive if we do not close off the pathways.

Will the COVID Vaccine Trial Work on Children?

The vaccine trials in children under 12 years of age are the same as the early adult trials. The further trials will include children as young as six months, and they will receive a range of doses to assess what triggers a good immune response without too many side effects. To ensure the vaccine's safety and effectiveness, the researchers will have a follow on those vaccinated children for months and years. During clinical trials, informed consent will be given by the participating individual in adults, and a legal guardian will agree with the involvement of a participating child.

How Do Children and Adults Respond to COVID-19 Vaccines?

The child's immune system produces a strong immune response to the vaccine as their body is filled up with fresh growing cells. During the early trials, children between 12 to 15 years of age received two doses of the Pfizer-BioNTech vaccine. They developed higher levels of virus-blocking antibodies when compared to individuals between 16 to 25 years of age who received the same dose. It is said that children who are still younger will receive the same immune response with a lowered dose. Children have a potent immune response and are more likely to develop a fever after the vaccination. So a balance should be maintained between triggering a strong immune response and minimizing the side effects. Recent studies have established a note on how a COVID-19 vaccine should be added to a child's immunization schedule to receive an expanded immunity.

Is the COVID-19 Vaccine Necessary For School Entry?

The effect of COVID-19 in children has affected their well-being, where education for children is the most priority. In addition, the pandemic situation has made people visit the pediatric emergency department as social isolation has increased the change in mental health and increased anxiety in children and families. However, it is important to understand that these changes are not because of the direct effects of the virus on children, but getting children vaccinated will help to reduce this anxiety and mental illness. Also plan on, safely opening up the essential services like schools as getting into normalcy is a priority for:

So to get into normalcy, vaccination for children is also highly needed to prevent the spread of the virus to the public and family members. When the vaccine gets approved, the health authorities will recommend when and how children should get it. Besides, the government will start deciding which vaccines are needed for school entry. At the same time, ensure that your kids are vaccinated against measles, cough, influenza, and any other that your pediatrician recommends.

Do Children Have the Same Side Effects as Adults?

There is no such information on children showing more or less side effects, but the information will be collected and furnished after the clinical trials. The researchers will monitor the safety and adverse effects of COVID-19 vaccines on children to evaluate the level of dosage needed.

When Will Vaccines Be Ready For Children?

Studies say that children between 12 to 17 years of age will have some vaccine soon, and the trials for children under 12 years of age have been started, and the vaccine for kids below 12 years of age will be available in the second half of 2022. The study says that:

It is known that infants and young children have protection even before vaccination and, when a mother is getting vaccinated, her antibodies are transmitted through the placenta and breast milk to the baby.

What Are the Companies Testing the COVID-19 Vaccine for Children?

Pfizer-BioNTech and Moderna are under clinical trials of their COVID-19 vaccines in children as young as:

Pfizer-BioNTech:

Pfizer's vaccine was approved for emergency use authorization by FDA for people above 16 years of age. Pfizer-BioNTech had 3,000 adolescents in its COVID vaccine trial, and it said that it has plans to launch a trial in children 6 months to 12 years of age. It says that they will enroll 144 children for their first study and later will enroll another 4,500 participants for further studies.

Moderna:

Moderna vaccine was approved by the FDA for emergency use authorization by FDA for people above 18 years of age. The Kidcove study is Moderna's newest trial, and it will test that this vaccine works in children between 6 months to 12 years of age. Depending on the age, it tests in two dose levels and in 28 days apart. Moderna enrolls 6,000 children for this trial and 3,000 participants in its another COVID-19 vaccine trial for 12 to 17 years of age.

Conclusion:

The COVID-19 vaccine is our best hope to help us overcome this pandemic. We are looking forward to the day when children can:

The vaccine availability for our children depends only on the results of the clinical trials. But based on the current research, it is possible to get a vaccine for some children before the 2022 school year begins. Even if you get vaccinated or not, following the COVID-19 safety protocols such as social distancing, frequently washing hands, staying away from crowded areas, wearing masks, and not touching the face frequently will help us reduce the spread and beat this pandemic.

ADVERTISEMENT
Article Resources

Last reviewed at:
09 Aug 2021  -  4 min read

RATING

16

Tags:

Comprehensive Medical Second Opinion.Submit your Case

Related Questions & Answers


COVID-19 Super-Spreaders

Article Overview: Coronavirus travels from place to place by infecting a person. These infected people with the novel Coronavirus are called super spreaders. During the COVID-19 pandemic, large and small gatherings are considered the growing focus of super-spreader events. Please read the article to know how a single infection spur causes a large outbreak among attendees.  Read Article


Dr. Disha Kandi Yermal
Dr. Disha Kandi Yermal
Pulmonologist

Introduction: The novel Coronavirus (SARS-CoV-2) travels from place to place by infecting one person at a time. These infected people are what epidemiologists call “super-spreaders.” One disturbing trend of the Coronavirus (COVID-19) pandemic is the growing focus of super-spreader event...  Read Article

COVID-19 Vaccines

Article Overview: A COVID-19 vaccine provides acquired immunity against the new Coronavirus. Read the article to know everything about the approved and undertrial vaccines. Read Article


Dr. Sneha Kannan
Dr. Sneha Kannan
Infectious Diseases Specialist

Many pharmaceutical companies worldwide are working on potential vaccines for the new Coronavirus disease (COVID-19). With COVID-19 cases continuing to grow, scientists and doctors are working day and night to develop vaccines to slow the pandemic and lessen its damage. How COVID-19 Vaccines Work? ...  Read Article

COVID-19 Vaccines in India

Article Overview: Two vaccines, Covishield and Covaxin, have been granted emergency use authorization in India. Read about these vaccines' indications, contraindications, precautions, and side effects. Read Article


Dr. Lochana
Dr. Lochana
Infectious Diseases Specialist

COVID-19 Vaccines: A vaccine is a medical or biological preparation that activates the immune system in an individual to fight pathogens that enter the body. Killed or deactivated form of the pathogen, toxin, or surface protein are commonly used to prepare a vaccine. The process of administration o...  Read Article

Popular Articles Most Popular Articles

Do you have a question on Coronavirus or Covid-19?

Ask a Doctor Online

* guaranteed answer within 4 hours.

Disclaimer: No content published on this website is intended to be a substitute for professional medical diagnosis, advice or treatment by a trained physician. Seek advice from your physician or other qualified healthcare providers with questions you may have regarding your symptoms and medical condition for a complete medical diagnosis. Do not delay or disregard seeking professional medical advice because of something you have read on this website.